ASN
SNDX icon

Advisory Services Network’s Syndax Pharmaceuticals SNDX Stock Holding History

Advisory Services Network’s Portfolio SNDX Stock Details SNDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-150
Closed -$2K – 3664
2020
Q3 		$2K Buy
+150
New +$2.29K ﹤0.01% 3190

Other funds holding SNDX

APM
Avidity Partners Management Dallas, Texas $624M AUM 250.2% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $7.48B AUM 104.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Advisory Services Network's SNDX Position: Q4 2020 in Review

Advisory Services Network sold out of Syndax Pharmaceuticals (SNDX) in Q4 2020, closing a stake of 150 shares — an estimated $2K sold.

Advisory Services Network first reported a position in SNDX in Q3 2020 and held it in 1 quarter. The position peaked at $2K in Q3 2020. 142 funds tracked by Wall St. Rank hold SNDX as of Q4 2020.

  • Advisory Services Network reported no remaining Syndax Pharmaceuticals position as of Q4 2020 after selling out during the quarter.
  • Advisory Services Network sold 150 Syndax Pharmaceuticals shares in Q4 2020, an estimated $2K.
  • Advisory Services Network first reported a position in Syndax Pharmaceuticals in Q3 2020 and held it in 1 quarter.
  • Advisory Services Network's Syndax Pharmaceuticals position peaked at $2K in Q3 2020.
  • 142 funds tracked by Wall St. Rank held Syndax Pharmaceuticals as of Q4 2020.

Based on Advisory Services Network's 13F filing for Q4 2020, filed 9 Feb 2021.